Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Overview
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Companies Involved in Therapeutics Development
DisperSol Technologies LLC
Johnson & Johnson
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Drug Profiles
abiraterone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
abiraterone acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
abiraterone acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LAE-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
orteronel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
seviteronel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit CYP17 for Prostate Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit CYP17 Lyase for Breast Cancer and Castration Resistant Prostate Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Dormant Products
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Discontinued Products
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygese or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 1.14.14.32) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Indications, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019


List of Tables


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indication, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by DisperSol Technologies LLC, H2 2019
Pipeline by Johnson & Johnson, H2 2019
Dormant Projects, H2 2019
Discontinued Products, H2 2019